• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 92 例肾上腺皮质癌的临床病理研究:从简化诊断算法到预后分层的建议。

Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.

机构信息

Division of Pathology, Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Turin, Italy.

出版信息

Histopathology. 2009 Nov;55(5):535-43. doi: 10.1111/j.1365-2559.2009.03423.x.

DOI:10.1111/j.1365-2559.2009.03423.x
PMID:19912359
Abstract

AIMS

Pathological diagnosis of adrenocortical carcinoma relies on several microscopic features commonly used in combination in different scoring systems that are sometimes subjective and/or time consuming. The aim was to investigate the impact of individual pathological parameters in the diagnosis and prognosis of adrenocortical carcinoma.

METHODS AND RESULTS

The series included 92 malignant cases and a control series of 47 adenomas, all classified according to Weiss score criteria. The presence of disruption of the reticular network, as highlighted by histochemical staining, was present in all adrenocortical carcinomas and the inclusion of at least one of the three following additional parameters - mitotic index >5/50 high-power fields (HPF), presence of necrosis and presence of vascular invasion - gave an algorithm with 100% sensitivity and specificity to recognize malignant tumours according to the Weiss system, with easier and more practical applicability. Moreover, on multivariate analysis, stage III/IV and mitotic count >9/50 HPF showed a strong adverse impact on disease-free and overall survival, leading to the identification of three risk groups affected by a significantly different prognosis.

CONCLUSIONS

We have defined an easy-to-perform and highly specific and sensitive algorithm for the diagnosis and prognostic categorization of adrenocortical tumours.

摘要

目的

肾上腺皮质癌的病理诊断依赖于几种常用于不同评分系统的微观特征,这些特征有时具有主观性和/或耗时。目的是研究个体病理参数对肾上腺皮质癌的诊断和预后的影响。

方法和结果

该系列包括 92 例恶性病例和 47 例腺瘤对照病例,均根据 Weiss 评分标准进行分类。所有肾上腺皮质癌中均存在网状网络中断,这是通过组织化学染色突出显示的,并且至少包含以下三个附加参数中的一个 - 有丝分裂指数>5/50 高倍视野(HPF),存在坏死和存在血管侵犯 - 根据 Weiss 系统,给出了一种具有 100%敏感性和特异性的算法,用于识别恶性肿瘤,其具有更简单、更实用的适用性。此外,多变量分析显示,III/IV 期和有丝分裂计数>9/50 HPF 对无病和总生存有强烈的不利影响,导致确定了三个受显著不同预后影响的风险组。

结论

我们已经定义了一种易于执行的、高度特异和敏感的算法,用于诊断和预后分类肾上腺皮质肿瘤。

相似文献

1
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.对 92 例肾上腺皮质癌的临床病理研究:从简化诊断算法到预后分层的建议。
Histopathology. 2009 Nov;55(5):535-43. doi: 10.1111/j.1365-2559.2009.03423.x.
2
Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.肾上腺皮质增生性病变的组织学标准:有丝分裂象变异性的价值
Am J Clin Pathol. 2007 Mar;127(3):398-408. doi: 10.1309/MCGUQ3R4A4WWN3LB.
3
Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.赫尔辛基评分——一种预测肾上腺皮质癌转移的新模型。
Hum Pathol. 2015 Mar;46(3):404-10. doi: 10.1016/j.humpath.2014.11.015. Epub 2014 Dec 9.
4
The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas.两种不同组织病理学评分系统对肾上腺皮质癌的预后价值。
Histopathology. 2007 Aug;51(2):239-45. doi: 10.1111/j.1365-2559.2007.02747.x. Epub 2007 Jun 25.
5
Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.标准化报告在肾上腺皮质癌中的影响:单中心临床病理回顾
J Clin Pathol. 2008 Aug;61(8):939-44. doi: 10.1136/jcp.2008.057067. Epub 2008 May 30.
6
Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.嗜酸细胞瘤性肾上腺皮质肿瘤:27 例诊断算法和线粒体 DNA 谱分析。
Am J Surg Pathol. 2011 Dec;35(12):1882-93. doi: 10.1097/PAS.0b013e31822da401.
7
Weiss criteria in large adrenocortical tumors: a validation study.大型肾上腺皮质肿瘤的魏斯标准:一项验证研究。
Indian J Pathol Microbiol. 2010 Apr-Jun;53(2):222-6. doi: 10.4103/0377-4929.64325.
8
The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.促纤维增生性肾上腺皮质肿瘤诊断的网状纤维算法:245 例未发表病例的多中心验证研究。
Am J Surg Pathol. 2013 Sep;37(9):1433-40. doi: 10.1097/PAS.0b013e31828d387b.
9
Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience.肾上腺皮质癌相关的临床特征和预后因素:拉希诊所医疗中心的经验
Am Surg. 2000 Jan;66(1):73-9.
10
[Adrenocortical tumors: mitotic index and nuclear size as criteria for differential diagnosis and prognosis].[肾上腺皮质肿瘤:有丝分裂指数和核大小作为鉴别诊断及预后的标准]
Arkh Patol. 1999 May-Jun;61(3):30-4.

引用本文的文献

1
Reticulin Framework Assessment in Neoplastic Endocrine Pathology.肿瘤性内分泌病理学中的网状纤维框架评估
Endocr Pathol. 2025 Jun 4;36(1):21. doi: 10.1007/s12022-025-09867-y.
2
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bisceglia criteria.当前林-魏斯-比塞利亚标准在预测具有不确定恶性潜能的嗜酸细胞性肾上腺皮质肿瘤以及根据林-魏斯-比塞利亚标准诊断的嗜酸细胞瘤预后不良方面的局限性。
Ther Adv Endocrinol Metab. 2025 Apr 30;16:20420188251328186. doi: 10.1177/20420188251328186. eCollection 2025.
3
Multicentric Retrospective Analysis of Oncocytic Adrenocortical Carcinoma: Insights into Clinical and Management Strategies.
嗜酸细胞性肾上腺皮质癌的多中心回顾性分析:对临床及管理策略的见解
Endocr Pathol. 2025 Apr 11;36(1):11. doi: 10.1007/s12022-025-09857-0.
4
Adrenal oncocytoma: a rare presentation of a benign 18 F-fluorodeoxyglucose PET avid virilising adrenal tumour.肾上腺嗜酸性细胞瘤:一种罕见的表现为18F-氟脱氧葡萄糖PET摄取阳性的良性男性化肾上腺肿瘤。
Nucl Med Commun. 2025 Apr 1;46(4):367-372. doi: 10.1097/MNM.0000000000001932. Epub 2024 Nov 28.
5
Updates on WHO 5th edition classification, molecular characteristics and tumor microenvironment of adrenocortical carcinomas.肾上腺皮质癌的世界卫生组织第5版分类、分子特征及肿瘤微环境的最新进展
Endocr J. 2025 Mar 3;72(3):243-257. doi: 10.1507/endocrj.EJ24-0466. Epub 2024 Nov 12.
6
Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.通过病理特征、免疫组织化学标志物和网状组织化学染色对肾上腺皮质癌进行诊断和预后评估。
Diagn Pathol. 2024 May 27;19(1):71. doi: 10.1186/s13000-024-01496-z.
7
Diagnostic Utility of a Modified Reticulin Algorithm in Pediatric Adrenocortical Neoplasms.改良网状纤维算法在儿科肾上腺皮质肿瘤中的诊断效用。
Am J Surg Pathol. 2024 Mar 1;48(3):309-316. doi: 10.1097/PAS.0000000000002174. Epub 2023 Dec 29.
8
Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma.EMP1、2、3 在肾上腺皮质肿瘤和嗜铬细胞瘤中的表达。
Int J Mol Sci. 2023 Aug 21;24(16):13016. doi: 10.3390/ijms241613016.
9
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.辅助米托坦与观察用于低级别、局限性肾上腺皮质癌(ADIUVO):一项国际、多中心、开放标签、随机、3 期临床试验和观察研究。
Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21.
10
Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes.肾上腺皮质癌中的代谢异质性影响患者预后。
JCI Insight. 2023 Aug 22;8(16):e167007. doi: 10.1172/jci.insight.167007.